Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,292 | -18,031 | -8,882 | -12,704 | -5,780 |
| Depreciation Amortization | 3,081 | 2,422 | 716 | 513 | 439 |
| Other Working Capital | -637 | -4,089 | 2,763 | 4,984 | -964 |
| Other Operating Activity | 12,259 | 561 | 682 | 598 | 130 |
| Operating Cash Flow | $-2,589 | $-19,137 | $-4,721 | $-6,609 | $-6,175 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,315 | -1,619 | -17,523 | -1,941 | -254 |
| Other Investing Activity | 2,497 | 8,411 | 22,012 | -353 | -39,833 |
| Investing Cash Flow | $1,182 | $6,792 | $4,489 | $-2,294 | $-40,087 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 6,544 | 16,367 | 5,245 | 1,537 | 54,719 |
| Financing Cash Flow | $6,544 | $16,367 | $5,245 | $1,537 | $54,719 |
| Beginning Cash Position | 13,691 | 9,669 | 4,656 | 12,022 | 3,565 |
| End Cash Position | 18,828 | 13,691 | 9,669 | 4,656 | 12,022 |
| Net Cash Flow | $5,137 | $4,022 | $5,013 | $-7,366 | $8,457 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,589 | -19,137 | -4,721 | -6,609 | -6,175 |
| Free Cash Flow | -2,589 | -19,137 | -4,721 | -6,609 | -6,175 |